用来治疗便秘及其兼容性处方
Xianhui Shen1, Liping Gong1, Rongrong Li2
1The Second Hospital of Shandong University, Jinan 250033, China.
Chinese herbal medicines
|November 28, 2024
概括
是一种传统的中医药,在治疗便秘方面表现有前途,为化学药物提供了更少副作用和复发问题的替代品. 这篇评论探讨了.
科学领域:
- 整合和补充医学是整合和补充医学.
- 胃肠病学 胃肠病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 便秘是一种普遍影响健康的消化系统疾病,目前的化学治疗方法面临诸如副作用和复发等局限性.
- 传统中国医学 (TCM) 将便秘的发病原因视为器官功能障碍和血气失衡.
- 是一种广泛使用的TCM草药,用于便秘,因为它具有寒冷的特性和苦味.
研究的目的:
- 综合审查的研究进展及其在治疗便秘中的兼容性处方.
- 为在便秘管理中的临床应用提供理论基础和药物指导.
- 确定未来的研究方向,用于在便秘治疗中的机制.
主要方法:
- 系统审查关于的现有文献及其有关便秘的处方.
- 基本实验研究和临床观察的分析.
- 审查涉及和中国专利药物的兼容性研究.
主要成果:
- 及其成分已在治疗便秘方面表现出治疗作用.
- 兼容性研究强调了当与其他TCM草药和药物结合使用时的协同效应.
- 证据涵盖从临床前研究到临床结果,支持的疗效.
结论:
- 及其配方的处方为便秘提供了可行的和有效的治疗选择.
- 对的特定作用机制进行进一步的研究是有必要的.
- 对于便秘的临床应用可以根据现有的研究和兼容性研究进行指导.
相关概念视频
Drugs for Treatment of Constipation-Predominant IBS
134
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
134
Drugs Affecting GI Tract Motility: Other Laxatives
170
Laxatives are primarily used to alleviate constipation, a common gastrointestinal disorder characterized by infrequent bowel movements and difficulty passing stools. They work by various mechanisms to increase the volume or frequency of bowel movements. The primary modes of action of laxatives include increasing stool bulk, softening the stool, stimulating intestinal motility, and osmotically drawing water into the intestines.
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
170
Drugs for Treatment of Diarrhea-Predominant IBS
147
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
147
Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives
186
Laxatives enhance bowel movements and alleviate constipation. They augment the stool's bulk, stimulate intestinal muscle contractions, draw water into the intestines, or soften the stool. There are five key types of laxatives: bulk laxatives, stimulant laxatives, osmotic laxatives, stool softeners, and lubricant laxatives.
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This...
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This...
186
Drugs for Treatment of Ulcerative Colitis in IBD
120
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
120
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents
179
Diarrhea is characterized by the occurrence of frequent, watery bowel movements. Various factors can trigger diarrhea, including viral or bacterial infections, foodborne illnesses, side effects from certain medications, and underlying digestive disorders. If not adequately managed, diarrhea can lead to complications such as dehydration, electrolyte imbalances, and nutrient deficiencies. Severe diarrhea can lead to significant weight loss, malnutrition, and weakened immune function.
Adsorbents...
Adsorbents...
179


